A detailed history of Janney Montgomery Scott LLC transactions in Organon & Co. stock. As of the latest transaction made, Janney Montgomery Scott LLC holds 250,507 shares of OGN stock, worth $4.88 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
250,507
Previous 263,051 4.77%
Holding current value
$4.88 Million
Previous $4.95 Million 4.87%
% of portfolio
0.02%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$17.45 - $21.96 $218,892 - $275,466
-12,544 Reduced 4.77%
250,507 $5.19 Million
Q1 2024

May 01, 2024

BUY
$13.78 - $18.8 $699,858 - $954,814
50,788 Added 23.93%
263,051 $4.95 Million
Q4 2023

Feb 07, 2024

SELL
$10.95 - $17.32 $310,914 - $491,784
-28,394 Reduced 11.8%
212,263 $3.06 Million
Q3 2023

Nov 08, 2023

SELL
$16.59 - $23.77 $259,683 - $372,071
-15,653 Reduced 6.11%
240,657 $4.18 Million
Q2 2023

Jul 26, 2023

BUY
$19.27 - $24.63 $2.62 Million - $3.34 Million
135,742 Added 112.59%
256,310 $5.33 Million
Q1 2023

Apr 28, 2023

SELL
$21.42 - $32.08 $121,130 - $181,412
-5,655 Reduced 4.48%
120,568 $2.84 Million
Q4 2022

Feb 01, 2023

BUY
$23.31 - $28.61 $1.01 Million - $1.24 Million
43,490 Added 52.57%
126,223 $3.53 Million
Q3 2022

Oct 25, 2022

SELL
$23.4 - $34.25 $26,839 - $39,284
-1,147 Reduced 1.37%
82,733 $1.94 Million
Q2 2022

Aug 03, 2022

BUY
$31.66 - $38.9 $2.66 Million - $3.26 Million
83,880 New
83,880 $2.91 Million
Q1 2022

May 04, 2022

SELL
$30.45 - $39.36 $2.76 Million - $3.57 Million
-90,728 Closed
0 $0
Q4 2021

Jan 27, 2022

SELL
$28.67 - $37.13 $759,468 - $983,573
-26,490 Reduced 22.6%
90,728 $2.76 Million
Q3 2021

Oct 29, 2021

SELL
$28.63 - $35.64 $834,908 - $1.04 Million
-29,162 Reduced 19.92%
117,218 $3.84 Million
Q2 2021

Jul 26, 2021

BUY
$28.45 - $38.0 $4.16 Million - $5.56 Million
146,380 New
146,380 $4.43 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.96B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.